Meniscus implant

About Biovature

Biovature is a private, pre-revenue platform company pioneering a novel 4D-Fibroprinting technology for advanced tissue engineering. Its core innovation integrates 3D printing with simultaneous fiber spinning to fabricate biomimetic, fibrous tissue constructs, targeting significant unmet needs in orthopedic repair. The company is currently in the pre-clinical development stage, working on specific implants and collaborating with academic and research institutions to advance its platform and initial product candidates.

About OrthoPreserve

OrthoPreserve is a Cleveland-based medical device startup founded in 2013, pioneering a novel composite biomaterial meniscus implant. The technology aims to address a critical treatment gap for patients with symptomatic meniscus dysfunction who are not yet candidates for knee replacement, offering a minimally invasive alternative to ineffective conservative treatments or meniscectomy. The company has secured key FDA designations, including Breakthrough Device and TAP program acceptance, and is fundraising to complete pre-clinical testing for an IDE submission targeted for 2027. Its leadership combines engineering innovation with deep clinical orthopedic expertise.

Therapeutic Areas